Trials / Completed
CompletedNCT00798447
Efficacy and Safety of a PN Regimen Containing n-3 Fatty Acid in Patients Considered After GI Surgery
A Prospective, Randomized, Double Blind Study to Compare the Efficacy and Safety of a n-3 Fatty Acid-containing Lipid Emulsion During Parenteral Nutrition in Patients Considered for Major Surgery for Gastric and Colorectal Cancer.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- B. Braun Melsungen AG · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of the impact of peri- and post-operative parenteral nutrition enriched with n-3 PUFA on post-operative inflammatory processes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MLF 541 | 22-24 h i.v. infusion, maximum 0.75 ml lipid emulsion per kg BW per hour |
| DRUG | Lipofundin MCT | 22-24 h iv.infusion, maximum 0.75 ml lipid emulsion per kg BW per hour |
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2010-10-01
- Completion
- 2010-10-01
- First posted
- 2008-11-26
- Last updated
- 2011-06-09
Locations
2 sites across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT00798447. Inclusion in this directory is not an endorsement.